MedPath

Sumatriptan Succinate

Sumatriptan succinate

Approved
Approval ID

68daf82a-334e-43ca-b4bb-5c66a82f52c8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 1, 2020

Manufacturers
FDA

Proficient Rx LP

DUNS: 079196022

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sumatriptan Succinate

PRODUCT DETAILS

NDC Product Code63187-049
Application NumberANDA076847
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateFebruary 1, 2020
Generic NameSumatriptan Succinate

INGREDIENTS (10)

sumatriptan succinateActive
Quantity: 50 mg in 1 1
Code: J8BDZ68989
Classification: ACTIM
croscarmellose sodiumInactive
Code: M28OL1HH48
Classification: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
talcInactive
Code: 7SEV7J4R1U
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT
mannitolInactive
Code: 3OWL53L36A
Classification: IACT
titanium dioxideInactive
Code: 15FIX9V2JP
Classification: IACT
triacetinInactive
Code: XHX3C3X673
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
Sumatriptan Succinate - FDA Approval | MedPath